rs1668875
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000501396.6(CASC8):n.547-5704C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.416 in 152,022 control chromosomes in the GnomAD database, including 13,489 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.42 ( 13489 hom., cov: 32)
Consequence
CASC8
ENST00000501396.6 intron
ENST00000501396.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0490
Publications
6 publications found
Genes affected
CASC8 (HGNC:45129): (cancer susceptibility 8)
POU5F1B (HGNC:9223): (POU class 5 homeobox 1B) This intronless gene was thought to be a transcribed pseudogene of POU class 5 homeobox 1, however, it has been reported that this gene can encode a functional protein. The encoded protein is nearly the same length as and highly similar to the POU class 5 homeobox 1 transcription factor, has been shown to be a weak transcriptional activator and may play a role in carcinogenesis and eye development. [provided by RefSeq, Apr 2009]
PCAT1 (HGNC:43022): (prostate cancer associated transcript 1) This gene produces a long non-coding RNA that promotes cell proliferation and is upregulated in prostate, colorectal, and other cancers. This RNA negatively regulates the BRCA2 tumor suppressor protein and positively regulates Myc oncoprotein. It contains binding sites for microRNAs, and may act as a sponge for microRNAs that regulate cell growth pathways. [provided by RefSeq, Dec 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.543 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.416 AC: 63119AN: 151904Hom.: 13462 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
63119
AN:
151904
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.416 AC: 63188AN: 152022Hom.: 13489 Cov.: 32 AF XY: 0.419 AC XY: 31116AN XY: 74284 show subpopulations
GnomAD4 genome
AF:
AC:
63188
AN:
152022
Hom.:
Cov.:
32
AF XY:
AC XY:
31116
AN XY:
74284
show subpopulations
African (AFR)
AF:
AC:
15883
AN:
41460
American (AMR)
AF:
AC:
7820
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
1480
AN:
3470
East Asian (EAS)
AF:
AC:
2895
AN:
5170
South Asian (SAS)
AF:
AC:
2608
AN:
4816
European-Finnish (FIN)
AF:
AC:
3734
AN:
10548
Middle Eastern (MID)
AF:
AC:
136
AN:
294
European-Non Finnish (NFE)
AF:
AC:
27117
AN:
67980
Other (OTH)
AF:
AC:
949
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1914
3829
5743
7658
9572
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
604
1208
1812
2416
3020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1955
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.